Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 164,137 $ 187,014
Marketable securities 10,428  
Accounts receivable, net 53,885 62,725
Inventories, net 38,822 34,093
Income tax receivable 1,859 1,626
Prepaid expenses and other current assets 14,016 19,187
Total current assets 283,147 304,645
Property and equipment, net 45,942 43,269
Goodwill 32,887 32,852
Operating lease right-of-use asset 21,108 21,653
Other assets 2,590 2,622
Total assets 385,674 405,041
Current liabilities    
Accounts payable and accrued expenses 32,183 33,974
Accrued payroll 10,757 11,190
Warranty reserve - current 8,075 7,790
Operating lease liability - current 3,570 3,515
Deferred revenue - current 8,794 8,880
Total current liabilities 63,379 65,349
Long-term liabilities    
Warranty reserve - noncurrent 12,018 12,123
Operating lease liability - noncurrent 19,179 19,764
Deferred revenue - noncurrent 9,801 10,399
Total liabilities 104,377 107,635
Commitments and contingencies (Note 9)
Stockholders' equity    
Common stock, $0.001 par value per share; 200,000,000 authorized; 23,120,786 and 22,941,643 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 23 23
Additional paid-in capital 316,127 312,126
Accumulated deficit (34,849) (14,500)
Accumulated other comprehensive loss (4) (243)
Total stockholders' equity 281,297 297,406
Total liabilities and stockholders' equity $ 385,674 $ 405,041